Brands Eyeing Chinese Expats in Singapore to Fuel Sales Post-COVID-19
As retail sales steadily recover, Chinese Expats have renewed their strong shopping sentiment with 63%…
5 years ago
Montréal Exchange Extends Trading Hours to Asia Pacific Time Zones
Canada’s Derivatives Exchange further expands global reach, syncing trading hours with Asia Pacific markets in…
5 years ago
Fusionex Signs MoU with Alliance Islamic Bank to Accelerate SMEs’ Halal Business Growth
PETALING JAYA, Malaysia--(BUSINESS WIRE)--#AllianceIslamicBank--Artificial Intelligence and Big Data technology market leader Fusionex recently signed an…
5 years ago
Rio Tinto to triple Weipa solar capacity and add battery storage to help power operations
MELBOURNE, Australia--(BUSINESS WIRE)--Rio Tinto has approved a new solar farm and battery storage at Weipa…
5 years ago
Datopotamab Deruxtecan Shows Encouraging Tumor Response in Patients with Advanced Non-Small Cell Lung Cancer with Actionable Genomic Alterations
Sub-analysis of TROPION-PanTumor01 phase 1 trial of datopotamab deruxtecan featured as late-breaking Mini Oral presentation…
5 years ago
Celltrion’s monoclonal antibody treatment for COVID-19, regdanvimab (CT-P59) becomes the first authorized COVID-19 treatment approved from the Korean Ministry of Food and Drug Safety (MFDS)
The approval marks the first time a monoclonal antibody treatment for COVID-19 received full approval…
5 years ago
ENHERTU® Demonstrated Robust and Durable Tumor Response of 54.9% in Patients with HER2 Mutant Metastatic Non-Small Cell Lung Cancer
First HER2 directed therapy to show a strong tumor response in this population Data from…
5 years ago
Enfusion Files Registration Statement with SEC for Proposed Initial Public Offering
NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)--Enfusion, Inc. ("Enfusion"), a leading provider of cloud-based…
5 years ago
Metals Acquisition Corp. Announces the Separate Trading of its Shares of Class A Ordinary Shares and Redeemable Warrants Commencing September 20, 2021
FORT WORTH, Texas--(BUSINESS WIRE)--Metals Acquisition Corp. (NYSE: MTAL.U) (the “Company”) announced that, commencing September 20,…
5 years ago
ENHERTU® Demonstrated Clinically Meaningful and Durable Response in Patients with HER2 Positive Advanced Gastric Cancer in DESTINY-Gastric02 Phase 2 Trial
First ENHERTU trial in Western patients with gastric cancer Efficacy and safety results consistent with…
5 years ago